JP Stock MarketDetailed Quotes

2160 GNI Group

Watchlist
  • 2131
  • -26-1.21%
20min DelayNot Open Mar 27 15:30 JST
107.02BMarket Cap100.76P/E (Static)

About GNI Group Company

GNI Group Ltd is a clinical stage drug development company. It works on the treatment of diseases that are more common in Asia, especially Japan and China. It is engaged in the discovery, development, manufacture, and sale of drugs for the treatment of cancer and inflammatory diseases.

Company Profile

Symbol2160
Company NameGNI Group
Founded2001-11-20
MarketTSE Growth
Employees867
Fiscal Year Ends12-31
AddressShinjuku Park Tower 3-7-1 Nishi-Shinjuku
Zip Code103-0023
Phone03-6214-3600
Websitewww.gnipharma.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Ying Luo, PhD
  • Director, Representative Executive Officer, President and Chief Executive Officer
  • --
  • Toshiya Kitagawa
  • Director, Executive Officer and Chief Financial Officer
  • --
  • Sekitani Kazuki
  • Director, Executive Officer and Chief Operating Officer
  • --
  • Thomas Eastling
  • Director
  • --
  • Ryosuke Matsui
  • Director
  • --
  • Kikuchi Kanako
  • Independent Director
  • --
  • Zhang Ping
  • Independent Director
  • --
  • Hideaki Sashiwa
  • Independent Director
  • --

Market Insights

Market Hot Picks Market Hot Picks
No. Symbol Price
Toyota Motor
7203
2828.5
CellSeed
7776
617
Metaplanet
3350
4795
4
Nippon Telegraph & Telephone
9432
150.0
5
Note
5243
2001
Log In for the Full List
Unlock Now